Population
Hypertensive patients in the United States
Design
Review
Authors
Loading...
Caution advised against short-term pharmacy restrictions; leaves open optimal long-term benefit designs in hypertension.
Cost containment in hypertension management requires considering long-term pharmacoeconomics rather than just short-term acquisition costs.
W.J. Elliott (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: